EQUITY ALERT: The Rosen Law Firm Announces Filing of Securities Class Action Lawsuit On Behalf of Unilife Corporation Investors

EQUITY ALERT: The Rosen Law Firm Announces Filing of Securities Class Action
Lawsuit On Behalf of Unilife Corporation Investors -- UNIS

NEW YORK, Nov. 9, 2013 (GLOBE NEWSWIRE) -- The Rosen Law Firm today announced
that a class action lawsuit has been filed on behalf of all purchasers of the
securities of Unilife Corporation (Nasdaq:UNIS) from July 13, 2011 through
September 9, 2013, alleging violations of federal securities law against the
Company and certain of its officers and directors.

To join the Unilife class action, go to the website at http://rosenlegal.com
or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or
email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class
action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS
CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY
ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY
RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, defendants issued materially false and misleading
statements about Unilife's true business and financial condition in violation
of the federal securities laws. Specifically, the complaint alleges that the
defendants concealed from investors that: (i) the Company's Unifill syringes
failed to comply with the U.S. Food and Drug Administration's ("FDA")
validation process; (ii) Unilife's Quality Management System failed to comply
with FDA regulations; (iii) Unilife intentionally increased its purchases of
Unifill component parts to lead suppliers into believing that Unilife was
producing at increased volumes even though its lacked customer demand or
manufacturing capacity to support such purchases; and (iv) consequently, the
Company's statements were materially false and misleading at all relevant
times. As a result, the complaint alleges that when this adverse information
was disclosed, it caused the price of Unilife stock to drop, damaging
investors.

A class action lawsuit has already been filed on behalf of Unilife investors.
If you wish to serve as lead plaintiff, you must move the Court no later than
December 31, 2013. If you wish to join the litigation or to discuss your
rights or interests regarding this class action, please contact, Phillip Kim,
Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or
via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.

The Rosen Law Firm focuses on prosecuting securities class action litigation
and actions involving financial fraud. The Rosen Law Firm represents investors
throughout the globe concentrating its practice in securities class actions.

CONTACT: Laurence Rosen, Esq.
         Phillip Kim, Esq.
         Kevin Chan, Esq.
         The Rosen Law Firm P.A.
         Tel:  (212) 686-1060
         Toll Free: 1-866--767-3653
         Fax: (212) 202-3827
         275 Madison Avenue, 34th Floor
         New York, New York 10016
         lrosen@rosenlegal.com
         pkim@rosenlegal.com
         kchan@rosenlegal.com
         www.rosenlegal.com
 
Press spacebar to pause and continue. Press esc to stop.